Crossmark

Clinical utility of receptor status prediction in breast cancer and misdiagnosis identification using deep learning on hematoxylin and eosin-stained slides

Crossref DOI link: https://doi.org/10.1038/s43856-024-00695-5

Published Online: 2024-12-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shamai, Gil https://orcid.org/0000-0002-8099-3027
Schley, Ran

Cretu, Alexandra

Neoran, Tal

Sabo, Edmond

Binenbaum, Yoav https://orcid.org/0000-0001-9901-7782
Cohen, Shachar

Goldman, Tal

Polónia, António https://orcid.org/0000-0001-8312-1681
Drumea, Keren

Stoliar, Karin

Kimmel, Ron
License Information

Text and Data Mining valid from 2024-12-20

Version of Record valid from 2024-12-20
More Information

Article History

Received: 7 August 2024

Accepted: 4 December 2024

First Online: 20 December 2024

Change Date: 28 February 2025

Change Type: Update

Change Details: In the version of the article initially published, the description of Supplementary Data 1 was incomplete and has now been amended.

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below